Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Smith, Sara
STROBE, NCT05664516: A Study of the Effects of Oxytocin in Adults With Obesity and Binge-eating Disorder	Recruiting	2	60	US	TNX-1900 (Tonix Pharmaceuticals), Placebo	Massachusetts General Hospital	Binge-eating Disorder	04/24	04/24
NCT05598736: Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain	Enrolling by invitation	N/A	60	Europe	FlowOx 2.0	Otivio AS	Multiple Sclerosis, Spasticity, Muscle, Pain	06/23	12/23
FO-NP002, NCT05562453: Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain	Active, not recruiting	N/A	56	Europe	FlowOx 2.0, Intermittent negative pressure (Active), FlowOx2.0 (Sham), Intermittent negative pressure (Sham)	Otivio AS	Multiple Sclerosis, Spasticity, Muscle, Pain, Chronic	07/23	08/23
DTU-STEMI, NCT03947619: Primary Unloading and Delayed Reperfusion in ST-Elevation Myocardial Infarction: The STEMI-DTU Trial	Recruiting	N/A	668	Europe, Canada, US	Impella CP® placement prior to reperfusion with Primary PCI	Abiomed Inc.	ST Elevation (STEMI) Myocardial Infarction of Anterior Wall	11/24	10/30
Panjrath, Gurusher
NCT04502316: Real-World Experience - Barostimâ„¢ Advancing the Level of Clinical Evidence (REBALANCE Registry)	Recruiting	N/A	5000	US	Barostimâ„¢ System	CVRx, Inc.	Heart Failure	06/28	06/28